IFITM3 and acute myeloid leukemia: High IFITM3 expression in patients with acute myeloid leukemia was associated with shorter event-free and overall survival, while no effect of IFITM expression was observed on patients undergoing allogeneic hematopoietic stem cell transplantation (162).